Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome (original) (raw)
Faculty of 1000 evaluation for The genetic landscape of the childhood cancer medulloblastoma
David Teachey
F1000 - Post-publication peer review of the biomedical literature, 2011
View PDFchevron_right
Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features
Wiesława Grajkowska
PLoS ONE, 2008
View PDFchevron_right
The Genetic Landscape of the Childhood Cancer Medulloblastoma
Meng Li
Science, 2011
View PDFchevron_right
MicroRNA profiling in human medulloblastoma
Elisabetta Ferretti, Italo Nofroni, Lucia Di Marcotullio
International Journal of Cancer, 2009
View PDFchevron_right
Impact of miRNA-mRNA Profiling and Their Correlation on Medulloblastoma Tumorigenesis
Ram Mahato
Molecular therapy. Nucleic acids, 2018
View PDFchevron_right
Integrated Analysis of miRNA and mRNA Expression in Childhood Medulloblastoma Compared with Neural Stem Cells
Laura Genovesi
PLOS One, 2011
View PDFchevron_right
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
Magnus Bäcklund
Acta Neuropathologica, 2012
View PDFchevron_right
miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children
Francesca Buttarelli
Diagnostics
View PDFchevron_right
Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches
Otilia Menyhart
Cancer and Metastasis Reviews, 2020
View PDFchevron_right
Molecular subgroups of medulloblastoma: the current consensus
Scott Pomeroy
Acta Neuropathologica, 2011
View PDFchevron_right
Molecular-Clinical Correlation in Pediatric Medulloblastoma: A Cohort Series Study of 52 Cases in Taiwan
Alice Yu
Cancers, 2020
View PDFchevron_right
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study
Simon Bailey
The Lancet. Oncology, 2017
View PDFchevron_right
The Molecular Landscape of Medulloblastoma in Teenagers and Young Adults
Omar Ahmad
Cancers, 2022
View PDFchevron_right
Genomics Identifies Medulloblastoma Subgroups That Are Enriched for Specific Genetic Alterations
Ching Lau
Journal of Clinical Oncology, 2006
View PDFchevron_right
Amplification and Overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in Medulloblastoma
Simon Bailey
PLoS ONE, 2009
View PDFchevron_right
Molecular fingerprints of medulloblastoma and their application to clinical practice
Scott Pomeroy
Future Oncology, 2011
View PDFchevron_right
MEDU-08. MiR-1253 POSSESSES NOVEL TUMOR SUPPRESSOR PROPERTIES IN PEDIATRIC MEDULLOBLASTOMA
Pranita Atri
Neuro-Oncology, 2019
View PDFchevron_right
MBRS-72. MiR-212 FUNCTIONS AS A TUMOR SUPPRESSOR GENE IN GROUP 3 MEDULLOBLASTOMA VIA TARGETING NUCLEAR FACTOR I/B (NFIB)
Pranita Atri
Neuro-Oncology, 2020
View PDFchevron_right
Medulloblastoma biology in the post-genomic era
Scott Pomeroy
Future Oncology, 2012
View PDFchevron_right
MicroRNAmRNA expression profiles associated with medulloblastoma subgroup 4
Mali Salmon-divon
Cancer Management and Research
View PDFchevron_right
Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma
Brad Poore
Cancers, 2020
View PDFchevron_right
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
Maura Massimino
Acta neuropathologica, 2016
View PDFchevron_right
Clinical and molecular stratification of disease risk in medulloblastoma
J. Lunec
British journal of cancer, 2001
View PDFchevron_right